WO2025132880 - TRANSMEMBRANE BETA BARRELS
National phase entry is expected:
Publication Number
WO/2025/132880
Publication Date
26.06.2025
International Application No.
PCT/EP2024/087538
International Filing Date
19.12.2024
Title **
[English]
TRANSMEMBRANE BETA BARRELS
[French]
TONNEAUX BÊTA TRANSMEMBRANAIRES
Applicants **
VIB VZW
VRIJE UNIVERSITEIT BRUSSEL
Inventors
VOROBIEVA, Anastassia
BERNER, Carolin
Priority Data
23218330.1
19.12.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2668 | |
| EPO | Filing, Examination, Granting | 15426 | |
| Japan | Filing, Examination, Granting | 2525 | |
| South Korea | Filing, Examination, Granting | 2825 | |
| USA | Filing, Examination, Granting | 9740 |
Total:
33,184
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a transmembrane beta barrel polypeptide. In another aspect, the invention concerns a nanopore comprising a lumen and a wall, wherein said wall comprises the transmembrane beta barrel polypeptide. In a further aspect, the invention concerns a pharmaceutical composition comprising the transmembrane beta barrel polypeptide and/or the nanopore. In further independent aspects the present invention pertains to a computer-implemented method for obtaining the transmembrane beta barrel polypeptide and method for producing the transmembrane beta barrel polypeptide in a host cell.[French]
La présente invention se rapporte à un polypeptide tonneau bêta transmembranaire. Selon un autre aspect, l'invention concerne un nanopore comprenant une lumière et une paroi, ladite paroi comprenant le polypeptide tonneau bêta transmembranaire. Dans un autre aspect, l'invention concerne une composition pharmaceutique comprenant le polypeptide tonneau bêta transmembranaire et/ou le nanopore. Dans d'autres aspects indépendants, la présente invention concerne un procédé mis en œuvre par ordinateur permettant d'obtenir le polypeptide tonneau bêta transmembranaire et un procédé permettant de produire le polypeptide tonneau bêta transmembranaire dans une cellule hôte.